Vita 34 closes 2023 with significantly better results than expected based on
preliminary figures

EQS-Ad-hoc: Vita 34 AG / Key word(s): Annual Results/Forecast
Vita 34 closes 2023 with significantly better results than expected based on
preliminary figures

19-Apr-2024 / 12:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Vita 34 closes 2023 with significantly better results than expected based on
preliminary figures

Leipzig, 19 April 2024 - According to the final key financial figures for
fiscal year 2023 available today, Vita 34 AG closed the year significantly
better in terms of earnings than expected by the Management Board on the
basis of the preliminary business figures from the end of January.
Accordingly, earnings before interest, taxes, depreciation and amortization
(EBITDA) amounted to EUR 5.6 million. In the publication of 31 January, the
Management Board had expected EBITDA of EUR 4.0 million. The deviation is
mainly related to higher positive effects from the harmonization of
accounting in accordance with IFRS 15 and due to a significantly more
positive assessment of the risks from hyperinflation in Turkey in the course
of the annual financial statements than anticipated in the preliminary
business figures.


End of Inside Information

---------------------------------------------------------------------------

Information and Explanation of the Issuer to this announcement:

Classification of earnings development in the overall development of the
Company:

Revenues amounted to EUR 77.1 million in 2023, which corresponds to a
year-on-year increase of 11.8 percent (2022: EUR 68.9 million). In the
current financial year, the Management Board expects a further improvement
in the Company's revenues and earnings situation. Accordingly, revenues of
between EUR 81 and 88 million and EBITDA of between EUR 6.5 and 8.0 million
are forecast for 2024.

The Company will publish the full annual report for the 2023 financial year
on 30 April 2024 in accordance with the financial calendar.


Contact:
Vita 34 AG
Investor Relations
Phone: +49 (0341) 48792 - 40
E-mail: ir@vita34.de

Company Profile

Vita 34 was founded in Leipzig in 1997 and today is by far the leading cell
bank in Europe and the third largest worldwide. As the first private
umbilical cord blood bank in Europe and a pioneer in cell banking, the
company has since offered the collection logistics, processing and storage
of stem cells from umbilical cord blood, umbilical cord tissue and other
postnatal tissues as a full-service provider for cryopreservation. Due to
the expansion of the business model following the merger with PBKM, the
company intends to invest in the areas of Cell & Gene therapies and CDMO.
The body's own cells are a valuable starting material for medical cell
therapy and are kept alive in the vapor of liquid nitrogen. Customers from
about 50 countries have already provided for the health of their families
with around one million units of stored biological material at Vita 34.


---------------------------------------------------------------------------

19-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Vita 34 AG
                   Deutscher Platz 5a
                   04103 Leipzig
                   Germany
   Phone:          +49(0341)48792-40
   Fax:            +49(0341)48792-39
   E-mail:         ir@vita34.de
   Internet:       www.vita34.de
   ISIN:           DE000A0BL849
   WKN:            A0BL84
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1884829

End of Announcement EQS News Service
---------------------------------------------------------------------------

1884829 19-Apr-2024 CET/CEST